Evidence map›Paper›PMID 36143382›Full record

ArticleLife (Basel, Switzerland)2022

PathoLive-Real-Time Pathogen Identification from Metagenomic Illumina Datasets.

Simon H Tausch, Tobias P Loka, Jakob M Schulze, Andreas Andrusch, Jeanette Klenner, Piotr Wojciech Dabrowski, Martin S Lindner, Andreas Nitsche, Bernhard Y Renard

Abstract read
In one paragraph

Article in Life (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. ganon2: up-to-date and scalable metagenomics analysis.NAR genomics and bioinformatics · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Simon H TauschNational Study Centre for Sequencing in Risk Assessment, Department Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany.ORCID 0000-0002-6874-233X
Tobias P LokaBioinformatics Division (MF 1), Department for Methods Development and Research Infrastructure, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0001-6380-5875
Jakob M SchulzeBioinformatics Division (MF 1), Department for Methods Development and Research Infrastructure, Robert Koch Institute, 13353 Berlin, Germany.
Andreas AndruschBioinformatics Division (MF 1), Department for Methods Development and Research Infrastructure, Robert Koch Institute, 13353 Berlin, Germany.
Jeanette KlennerCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), 13353 Berlin, Germany.
Piotr Wojciech DabrowskiBioinformatics Division (MF 1), Department for Methods Development and Research Infrastructure, Robert Koch Institute, 13353 Berlin, Germany.ORCID 0000-0003-4893-805X
Martin S LindnerBioinformatics Division (MF 1), Department for Methods Development and Research Infrastructure, Robert Koch Institute, 13353 Berlin, Germany.
Andreas NitscheCentre for Biological Threats and Special Pathogens, Highly Pathogenic Viruses (ZBS 1), 13353 Berlin, Germany.ORCID 0000-0001-8185-3176
Bernhard Y RenardBioinformatics Division (MF 1), Department for Methods Development and Research Infrastructure, Robert Koch Institute, 13353 Berlin, Germany.

Funding

Federal Ministry of Education and Research Live-DREAMFederal Ministry of Health 2515NIK043
6 · The paper itself

Abstract

Over the past years, NGS has become a crucial workhorse for open-view pathogen diagnostics. Yet, long turnaround times result from using massively parallel high-throughput technologies as the analysis can only be performed after sequencing has finished. The interpretation of results can further be challenged by contaminations, clinically irrelevant sequences, and the sheer amount and complexity of the data. We implemented PathoLive, a real-time diagnostics pipeline for the detection of pathogens from clinical samples hours before sequencing has finished. Based on real-time alignment with HiLive2, mappings are scored with respect to common contaminations, low-entropy areas, and sequences of widespread, non-pathogenic organisms. The results are visualized using an interactive taxonomic tree that provides an easily interpretable overview of the relevance of hits. For a human plasma sample that was spiked in vitro with six pathogenic viruses, all agents were clearly detected after only 40 of 200 sequencing cycles. For a real-world sample from Sudan, the results correctly indicated the presence of Crimean-Congo hemorrhagic fever virus. In a second real-world dataset from the 2019 SARS-CoV-2 outbreak in Wuhan, we found the presence of a SARS coronavirus as the most relevant hit without the novel virus reference genome being included in the database. For all samples, clinically irrelevant hits were correctly de-emphasized. Our approach is valuable to obtain fast and accurate NGS-based pathogen identifications and correctly prioritize and visualize them based on their clinical significance: PathoLive is open source and available on GitLab and BioConda.

Indexed as

diagnosticsinfectious diseaseslive sequencingmetagenomicsNGSviruses

Identifiers

PMID36143382
PMCPMC9505849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.